Skip to main content
Figure 3 | Molecular and Cellular Therapies

Figure 3

From: Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies

Figure 3

Flow cytometry of autologous human induced pluripotent stem cells. Autologous human induced pluripotent stem cells (ahiPSCs) were labeled with the antibodies highlighting the hallmark biomarkers: A: anti-SSEA-3; B: anti-SSEA-4; C: anti-TRA-1-60; D: anti-TRA-1-81. The variability in the spectra between the patients was addressed by calculating the full width at half maximum (FWHM) and superimposing over the spectrum.

Back to article page